InDex Pharmaceuticals has been granted a new patent in Europe for the commercial formulation of cobitolimod ...Middle East

PR Newswire - News
STOCKHOLM, Aug. 2, 2023 /PRNewswire/ -- InDex Pharmaceuticals Holding AB (publ) today announced that a new formulation patent for the drug candidate cobitolimod has been granted by the European Patent Office. The patent provides protection of the enema formulation of cobitolimod, that is...

Hence then, the article about index pharmaceuticals has been granted a new patent in europe for the commercial formulation of cobitolimod was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( InDex Pharmaceuticals has been granted a new patent in Europe for the commercial formulation of cobitolimod )

Apple Storegoogle play

Last updated :

Also on site :